The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung Injury

Prolonged exposure to 100% O(2) causes hyperoxic acute lung injury (HALI), characterized by alveolar epithelial cell injury and death. We previously demonstrated that the murine chitinase-like protein, breast regression protein (BRP)-39 and its human homolog, YKL-40, inhibit cellular apoptosis. Howe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2010-10, Vol.182 (7), p.918-928
Hauptverfasser: MYUNG HYUN SOHN, KANG, Min-Jong, MATSUURA, Hiroshi, BHANDARI, Vineet, CHEN, Ning-Yuan, CHUN GEUN LEE, ELIAS, Jack A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 928
container_issue 7
container_start_page 918
container_title American journal of respiratory and critical care medicine
container_volume 182
creator MYUNG HYUN SOHN
KANG, Min-Jong
MATSUURA, Hiroshi
BHANDARI, Vineet
CHEN, Ning-Yuan
CHUN GEUN LEE
ELIAS, Jack A
description Prolonged exposure to 100% O(2) causes hyperoxic acute lung injury (HALI), characterized by alveolar epithelial cell injury and death. We previously demonstrated that the murine chitinase-like protein, breast regression protein (BRP)-39 and its human homolog, YKL-40, inhibit cellular apoptosis. However, the regulation and roles of these molecules in hyperoxia have not been addressed. We hypothesized that BRP-39 and YKL-40 (also called chitinase-3-like 1) play important roles in the pathogenesis of HALI. We characterized the regulation of BRP-39 during HALI and the responses induced by hyperoxia in wild-type mice, BRP-39-null (-/-) mice, and BRP-39(-/-) mice in which YKL-40 was overexpressed in respiratory epithelium. We also compared the levels of tracheal aspirate YKL-40 in premature newborns with respiratory failure. These studies demonstrate that hyperoxia inhibits BRP-39 in vivo in the murine lung and in vitro in epithelial cells. They also demonstrate that BRP-39(-/-) mice have exaggerated permeability, protein leak, oxidation, inflammatory, chemokine, and epithelial apoptosis responses, and experience premature death in 100% O(2). Lastly, they demonstrate that YKL-40 ameliorates HALI, prolongs survival in 100% O(2), and rescues the exaggerated injury response in BRP-39(-/-) animals. In accord with these findings, the levels of tracheal aspirate YKL-40 were lower in premature infants treated with hyperoxia for respiratory failure who subsequently experienced bronchopulmonary dysplasia or death compared with those that did not experience these complications. These studies demonstrate that hyperoxia inhibits BRP-39/YKL-40, and that BRP-39 and YKL-40 are critical regulators of oxidant injury, inflammation, and epithelial apoptosis in the murine and human lung.
doi_str_mv 10.1164/rccm.200912-1793oc
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2970863</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2159129931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-c2ebc6306bd01cdcd5a2d12945f588b4b9f7a125091765ca35db64a48d1b60bb3</originalsourceid><addsrcrecordid>eNpdkV1rFDEUhgex2Fr9A15IEMSrtPmeyY1QF7WlCxWpoFchX7ObdTbZJjPi_nuz7LZar3LIec7hfc_bNK8wOsNYsPNs7fqMICQxgbiVNNknzQnmlEMmW_S01qilkDH5_bh5XsoKIUw6jJ41xwRx3gmKT5rN7dKD2TKMIeri4RB-evAlp9GHWMCH7HUZwVe_yL6UkOJ9C1IJdHTgx_UcMrQDpkGPHlxuNz6n30HDEN1kvQMXdqr_8ykuwFVcTXn7ojnq9VD8y8N72nz79PF2dgnnN5-vZhdzaDlhI7TEGysoEsYhbJ11XBOHiWS8511nmJF9qzHh1XwruNWUOyOYZp3DRiBj6Gnzfr93M5m1d9bHMetBbXJY67xVSQf1uBPDUi3SL0Xq7ept6oJ3hwU53U2-jGodivXDoKNPU1Etr_K6qqiSb_4jV2nKsbqrUIulkExUiOwhm1Mp2fcPUjBSuzjVLk61j1Pt4ryZ1aHX_5p4GLnPrwJvD4AuVg991tGG8pejFNGOcPoHZV-qPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>757196946</pqid></control><display><type>article</type><title>The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung Injury</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>MYUNG HYUN SOHN ; KANG, Min-Jong ; MATSUURA, Hiroshi ; BHANDARI, Vineet ; CHEN, Ning-Yuan ; CHUN GEUN LEE ; ELIAS, Jack A</creator><creatorcontrib>MYUNG HYUN SOHN ; KANG, Min-Jong ; MATSUURA, Hiroshi ; BHANDARI, Vineet ; CHEN, Ning-Yuan ; CHUN GEUN LEE ; ELIAS, Jack A</creatorcontrib><description>Prolonged exposure to 100% O(2) causes hyperoxic acute lung injury (HALI), characterized by alveolar epithelial cell injury and death. We previously demonstrated that the murine chitinase-like protein, breast regression protein (BRP)-39 and its human homolog, YKL-40, inhibit cellular apoptosis. However, the regulation and roles of these molecules in hyperoxia have not been addressed. We hypothesized that BRP-39 and YKL-40 (also called chitinase-3-like 1) play important roles in the pathogenesis of HALI. We characterized the regulation of BRP-39 during HALI and the responses induced by hyperoxia in wild-type mice, BRP-39-null (-/-) mice, and BRP-39(-/-) mice in which YKL-40 was overexpressed in respiratory epithelium. We also compared the levels of tracheal aspirate YKL-40 in premature newborns with respiratory failure. These studies demonstrate that hyperoxia inhibits BRP-39 in vivo in the murine lung and in vitro in epithelial cells. They also demonstrate that BRP-39(-/-) mice have exaggerated permeability, protein leak, oxidation, inflammatory, chemokine, and epithelial apoptosis responses, and experience premature death in 100% O(2). Lastly, they demonstrate that YKL-40 ameliorates HALI, prolongs survival in 100% O(2), and rescues the exaggerated injury response in BRP-39(-/-) animals. In accord with these findings, the levels of tracheal aspirate YKL-40 were lower in premature infants treated with hyperoxia for respiratory failure who subsequently experienced bronchopulmonary dysplasia or death compared with those that did not experience these complications. These studies demonstrate that hyperoxia inhibits BRP-39/YKL-40, and that BRP-39 and YKL-40 are critical regulators of oxidant injury, inflammation, and epithelial apoptosis in the murine and human lung.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200912-1793oc</identifier><identifier>PMID: 20558631</identifier><language>eng</language><publisher>New York, NY: American Thoracic Society</publisher><subject>Acute Lung Injury - physiopathology ; Adipokines ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Apoptosis ; Arthritis ; Asthma ; Biological and medical sciences ; Blood and lymphatic vessels ; Bronchopulmonary Dysplasia - physiopathology ; C. Critical Care ; Cardiology. Vascular system ; Cells, Cultured ; Chitinase ; Chitinase-3-Like Protein 1 ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Female ; Glycoproteins - metabolism ; Humans ; Hyperoxia ; Hyperoxia - physiopathology ; Infant, Newborn ; Infant, Premature ; Inflammation ; Intensive care medicine ; Laboratories ; Lectins - metabolism ; Lung diseases ; Male ; Medical sciences ; Mice ; Mice, Transgenic ; Mutation ; Pathogenesis ; Premature babies ; Premature birth ; Proteins ; Respiratory failure ; Respiratory Mucosa - metabolism ; Survival Analysis</subject><ispartof>American journal of respiratory and critical care medicine, 2010-10, Vol.182 (7), p.918-928</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright American Thoracic Society Oct 1, 2010</rights><rights>Copyright © 2010, American Thoracic Society 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-c2ebc6306bd01cdcd5a2d12945f588b4b9f7a125091765ca35db64a48d1b60bb3</citedby><cites>FETCH-LOGICAL-c524t-c2ebc6306bd01cdcd5a2d12945f588b4b9f7a125091765ca35db64a48d1b60bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,4011,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23303825$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20558631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MYUNG HYUN SOHN</creatorcontrib><creatorcontrib>KANG, Min-Jong</creatorcontrib><creatorcontrib>MATSUURA, Hiroshi</creatorcontrib><creatorcontrib>BHANDARI, Vineet</creatorcontrib><creatorcontrib>CHEN, Ning-Yuan</creatorcontrib><creatorcontrib>CHUN GEUN LEE</creatorcontrib><creatorcontrib>ELIAS, Jack A</creatorcontrib><title>The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung Injury</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Prolonged exposure to 100% O(2) causes hyperoxic acute lung injury (HALI), characterized by alveolar epithelial cell injury and death. We previously demonstrated that the murine chitinase-like protein, breast regression protein (BRP)-39 and its human homolog, YKL-40, inhibit cellular apoptosis. However, the regulation and roles of these molecules in hyperoxia have not been addressed. We hypothesized that BRP-39 and YKL-40 (also called chitinase-3-like 1) play important roles in the pathogenesis of HALI. We characterized the regulation of BRP-39 during HALI and the responses induced by hyperoxia in wild-type mice, BRP-39-null (-/-) mice, and BRP-39(-/-) mice in which YKL-40 was overexpressed in respiratory epithelium. We also compared the levels of tracheal aspirate YKL-40 in premature newborns with respiratory failure. These studies demonstrate that hyperoxia inhibits BRP-39 in vivo in the murine lung and in vitro in epithelial cells. They also demonstrate that BRP-39(-/-) mice have exaggerated permeability, protein leak, oxidation, inflammatory, chemokine, and epithelial apoptosis responses, and experience premature death in 100% O(2). Lastly, they demonstrate that YKL-40 ameliorates HALI, prolongs survival in 100% O(2), and rescues the exaggerated injury response in BRP-39(-/-) animals. In accord with these findings, the levels of tracheal aspirate YKL-40 were lower in premature infants treated with hyperoxia for respiratory failure who subsequently experienced bronchopulmonary dysplasia or death compared with those that did not experience these complications. These studies demonstrate that hyperoxia inhibits BRP-39/YKL-40, and that BRP-39 and YKL-40 are critical regulators of oxidant injury, inflammation, and epithelial apoptosis in the murine and human lung.</description><subject>Acute Lung Injury - physiopathology</subject><subject>Adipokines</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Arthritis</subject><subject>Asthma</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Bronchopulmonary Dysplasia - physiopathology</subject><subject>C. Critical Care</subject><subject>Cardiology. Vascular system</subject><subject>Cells, Cultured</subject><subject>Chitinase</subject><subject>Chitinase-3-Like Protein 1</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Female</subject><subject>Glycoproteins - metabolism</subject><subject>Humans</subject><subject>Hyperoxia</subject><subject>Hyperoxia - physiopathology</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Inflammation</subject><subject>Intensive care medicine</subject><subject>Laboratories</subject><subject>Lectins - metabolism</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mutation</subject><subject>Pathogenesis</subject><subject>Premature babies</subject><subject>Premature birth</subject><subject>Proteins</subject><subject>Respiratory failure</subject><subject>Respiratory Mucosa - metabolism</subject><subject>Survival Analysis</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkV1rFDEUhgex2Fr9A15IEMSrtPmeyY1QF7WlCxWpoFchX7ObdTbZJjPi_nuz7LZar3LIec7hfc_bNK8wOsNYsPNs7fqMICQxgbiVNNknzQnmlEMmW_S01qilkDH5_bh5XsoKIUw6jJ41xwRx3gmKT5rN7dKD2TKMIeri4RB-evAlp9GHWMCH7HUZwVe_yL6UkOJ9C1IJdHTgx_UcMrQDpkGPHlxuNz6n30HDEN1kvQMXdqr_8ykuwFVcTXn7ojnq9VD8y8N72nz79PF2dgnnN5-vZhdzaDlhI7TEGysoEsYhbJ11XBOHiWS8511nmJF9qzHh1XwruNWUOyOYZp3DRiBj6Gnzfr93M5m1d9bHMetBbXJY67xVSQf1uBPDUi3SL0Xq7ept6oJ3hwU53U2-jGodivXDoKNPU1Etr_K6qqiSb_4jV2nKsbqrUIulkExUiOwhm1Mp2fcPUjBSuzjVLk61j1Pt4ryZ1aHX_5p4GLnPrwJvD4AuVg991tGG8pejFNGOcPoHZV-qPQ</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>MYUNG HYUN SOHN</creator><creator>KANG, Min-Jong</creator><creator>MATSUURA, Hiroshi</creator><creator>BHANDARI, Vineet</creator><creator>CHEN, Ning-Yuan</creator><creator>CHUN GEUN LEE</creator><creator>ELIAS, Jack A</creator><general>American Thoracic Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20101001</creationdate><title>The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung Injury</title><author>MYUNG HYUN SOHN ; KANG, Min-Jong ; MATSUURA, Hiroshi ; BHANDARI, Vineet ; CHEN, Ning-Yuan ; CHUN GEUN LEE ; ELIAS, Jack A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-c2ebc6306bd01cdcd5a2d12945f588b4b9f7a125091765ca35db64a48d1b60bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acute Lung Injury - physiopathology</topic><topic>Adipokines</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Arthritis</topic><topic>Asthma</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Bronchopulmonary Dysplasia - physiopathology</topic><topic>C. Critical Care</topic><topic>Cardiology. Vascular system</topic><topic>Cells, Cultured</topic><topic>Chitinase</topic><topic>Chitinase-3-Like Protein 1</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Female</topic><topic>Glycoproteins - metabolism</topic><topic>Humans</topic><topic>Hyperoxia</topic><topic>Hyperoxia - physiopathology</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Inflammation</topic><topic>Intensive care medicine</topic><topic>Laboratories</topic><topic>Lectins - metabolism</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mutation</topic><topic>Pathogenesis</topic><topic>Premature babies</topic><topic>Premature birth</topic><topic>Proteins</topic><topic>Respiratory failure</topic><topic>Respiratory Mucosa - metabolism</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MYUNG HYUN SOHN</creatorcontrib><creatorcontrib>KANG, Min-Jong</creatorcontrib><creatorcontrib>MATSUURA, Hiroshi</creatorcontrib><creatorcontrib>BHANDARI, Vineet</creatorcontrib><creatorcontrib>CHEN, Ning-Yuan</creatorcontrib><creatorcontrib>CHUN GEUN LEE</creatorcontrib><creatorcontrib>ELIAS, Jack A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MYUNG HYUN SOHN</au><au>KANG, Min-Jong</au><au>MATSUURA, Hiroshi</au><au>BHANDARI, Vineet</au><au>CHEN, Ning-Yuan</au><au>CHUN GEUN LEE</au><au>ELIAS, Jack A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung Injury</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>182</volume><issue>7</issue><spage>918</spage><epage>928</epage><pages>918-928</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Prolonged exposure to 100% O(2) causes hyperoxic acute lung injury (HALI), characterized by alveolar epithelial cell injury and death. We previously demonstrated that the murine chitinase-like protein, breast regression protein (BRP)-39 and its human homolog, YKL-40, inhibit cellular apoptosis. However, the regulation and roles of these molecules in hyperoxia have not been addressed. We hypothesized that BRP-39 and YKL-40 (also called chitinase-3-like 1) play important roles in the pathogenesis of HALI. We characterized the regulation of BRP-39 during HALI and the responses induced by hyperoxia in wild-type mice, BRP-39-null (-/-) mice, and BRP-39(-/-) mice in which YKL-40 was overexpressed in respiratory epithelium. We also compared the levels of tracheal aspirate YKL-40 in premature newborns with respiratory failure. These studies demonstrate that hyperoxia inhibits BRP-39 in vivo in the murine lung and in vitro in epithelial cells. They also demonstrate that BRP-39(-/-) mice have exaggerated permeability, protein leak, oxidation, inflammatory, chemokine, and epithelial apoptosis responses, and experience premature death in 100% O(2). Lastly, they demonstrate that YKL-40 ameliorates HALI, prolongs survival in 100% O(2), and rescues the exaggerated injury response in BRP-39(-/-) animals. In accord with these findings, the levels of tracheal aspirate YKL-40 were lower in premature infants treated with hyperoxia for respiratory failure who subsequently experienced bronchopulmonary dysplasia or death compared with those that did not experience these complications. These studies demonstrate that hyperoxia inhibits BRP-39/YKL-40, and that BRP-39 and YKL-40 are critical regulators of oxidant injury, inflammation, and epithelial apoptosis in the murine and human lung.</abstract><cop>New York, NY</cop><pub>American Thoracic Society</pub><pmid>20558631</pmid><doi>10.1164/rccm.200912-1793oc</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2010-10, Vol.182 (7), p.918-928
issn 1073-449X
1535-4970
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2970863
source Journals@Ovid Ovid Autoload; MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Acute Lung Injury - physiopathology
Adipokines
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Apoptosis
Arthritis
Asthma
Biological and medical sciences
Blood and lymphatic vessels
Bronchopulmonary Dysplasia - physiopathology
C. Critical Care
Cardiology. Vascular system
Cells, Cultured
Chitinase
Chitinase-3-Like Protein 1
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Glycoproteins - metabolism
Humans
Hyperoxia
Hyperoxia - physiopathology
Infant, Newborn
Infant, Premature
Inflammation
Intensive care medicine
Laboratories
Lectins - metabolism
Lung diseases
Male
Medical sciences
Mice
Mice, Transgenic
Mutation
Pathogenesis
Premature babies
Premature birth
Proteins
Respiratory failure
Respiratory Mucosa - metabolism
Survival Analysis
title The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung Injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T07%3A53%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Chitinase-like%20Proteins%20Breast%20Regression%20Protein-39%20and%20YKL-40%20Regulate%20Hyperoxia-induced%20Acute%20Lung%20Injury&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=MYUNG%20HYUN%20SOHN&rft.date=2010-10-01&rft.volume=182&rft.issue=7&rft.spage=918&rft.epage=928&rft.pages=918-928&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200912-1793oc&rft_dat=%3Cproquest_pubme%3E2159129931%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=757196946&rft_id=info:pmid/20558631&rfr_iscdi=true